Rhodopsin (RHO) (C-Term) antibody

Details for Product No. ABIN350797
Request Want additional data for this product?

The Independent Validation Initiative strives to provide you with high quality data. Find out more

 
Antigen
Synonyms
CSNBAD1, OPN2, RP4, Rh, RH1, zfo2, zfrho, fi06d11, wu:fi06d11, Noerg1, Opn2, Ops, PIGRHO1, RDP1, opn2, rh1, rp4, xrho, CG5279, DMELRH5, Dm Rh5, Dmel\\CG5279, RH5, rh5, CG9668, DMELRH4, Dm Rh4, Dmel\\C ... show more
CSNBAD1, OPN2, RP4, Rh, RH1, zfo2, zfrho, fi06d11, wu:fi06d11, Noerg1, Opn2, Ops, PIGRHO1, RDP1, opn2, rh1, rp4, xrho, CG5279, DMELRH5, Dm Rh5, Dmel\\CG5279, RH5, rh5, CG9668, DMELRH4, Dm Rh4, Dmel\\CG9668, FBgn0003250, RH4, rh4, CG5192, DMELRH6, Dm Rh6, Dmel\\CG5192, R8, RH6, rh6, 143283_at, 1F9, BEST:GH11778, CG4550, DMELRH1, DRh1, Dm Rh1, DmRh1, Dmel\\CG4550, FBgn0002940, Nina E, NinaE, R, Rh-1, Rh1, Rh1(ninaE), Rh1/ninaE, opsin, ora, rh1/ninaE, rhodopsin, CG10888, DMELRH3, Dm Rh3, Dmel\\CG10888, FBgn0003249, RH3, rh3, ops, RHO, kfh-rh show less
Epitope
C-Term
(5), (5), (4), (2), (1), (1), (1), (1), (1), (1), (1)
Reactivity
Human
(44), (33), (23), (15), (7), (5), (5), (5), (4), (4), (3), (2), (2), (2), (2), (2), (1), (1), (1), (1), (1), (1), (1)
Host
Sheep
(40), (31), (3)
Clonality
Polyclonal
Conjugate
Un-conjugated
(3)
Application
Immunohistochemistry (IHC), Western Blotting (WB)
(60), (35), (27), (25), (20), (18), (15), (8), (4), (1)
Pubmed 10 references available
Catalog no. ABIN350797
Quantity 100 µL
Price
454.67 $   Plus shipping costs $45.00
Options
Shipping to United States (Change)
Availability Will be delivered in 7 to 8 Business Days

Order hotline:

  • +1 404 474 4654
  • +1 888 205 9894 (TF)
Immunogen A synthetic peptide from c-terminal region of human Rhodopsin (OPSD, Opsin-2) conjugated to an immunogenic carrier protein was used as the antigen. The peptide is homologous in mouse and rat.
Specificity Specific for ATG4D.
Purification whole serum
Alternative Name Rhodopsin
Background Function: Photoreceptor required for image-forming vision at low light intensity. Required for photoreceptor cell viability after birth. Light-induced isomerization of 11-cis to all-trans retinal triggers a conformational change leading to G-protein activation and release of all-trans retinal. BIOPHYSICOCHEMICAL PROPERTIES: Absorption:       Abs(max)=495 nm,
Subcellular location: Membrane, Multi-pass membrane protein.
Tissue specificity: Rod shaped photoreceptor cells which mediates vision in dim light. PTM: Phosphorylated on some or all of the serine and threonine residues present in the C-terminal region. DISEASE: Defects in RHO are the cause of retinitis pigmentosa type 4 (RP4). RP leads to degeneration of retinal photoreceptor cells. Patients typically have night vision blindness and loss of midperipheral visual field. As their condition progresses, they lose their far peripheral visual field and eventually central vision as well. RP4 inheritance is autosomal dominant. DISEASE: Defects in RHO are a cause of retinitis pigmentosa autosomal recessive (ARRP). DISEASE: Defects in RHO are a cause of autosomal dominant congenital stationary night blindness 1 (CSNBAD1), also known as rhodopsin-related congenital stationary night blindness. Congenital stationary night blindness is a nonprogressive retinal disorder characterized by impaired night vision and ocular symptoms such as myopia, hyperopia, nystagmus and reduced visual acuity. Also known as: Rhodopsin, opsin-2, RHO, OPN2, RP4, MGC138309, MGC138311.
UniProt Q86TL0
Research Area Cancer, Autophagy, Proteolysis / Ubiquitin
Application Notes A dilution of 1 : 300 to 1 : 2000 is recommended.
The optimal dilution should be determined by the end user.
Not yet tested in other applications.
Restrictions For Research Use only
Format Liquid
Reconstitution Reconstitute in 100 µL of sterile water. Centrifuge to remove any insoluble material.
Handling Advice Avoid freeze and thaw cycles.
Storage -20 °C
Storage Comment Maintain the reconstituted antibodies frozen at -20 °C for long term storage and refrigerated at 2-8 °C for a shorter term.
Expiry Date 12 months
General Farrar, Findlay, Kumar-Singh et al.: "Autosomal dominant retinitis pigmentosa: a novel mutation in the rhodopsin gene in the original 3q linked family." in: Human molecular genetics, Vol. 1, Issue 9, pp. 769-71, 1993 (PubMed).

Sung, Davenport, Hennessey et al.: "Rhodopsin mutations in autosomal dominant retinitis pigmentosa." in: Proceedings of the National Academy of Sciences of the United States of America, Vol. 88, Issue 15, pp. 6481-5, 1991 (PubMed).

Dryja, McGee, Reichel et al.: "A point mutation of the rhodopsin gene in one form of retinitis pigmentosa." in: Nature, Vol. 343, Issue 6256, pp. 364-6, 1990 (PubMed).

Nathans, Hogness: "Isolation and nucleotide sequence of the gene encoding human rhodopsin." in: Proceedings of the National Academy of Sciences of the United States of America, Vol. 81, Issue 15, pp. 4851-5, 1984 (PubMed).

Macke, Hennessey, Nathans: "Rhodopsin mutation proline347-to-alanine in a family with autosomal dominant retinitis pigmentosa indicates an important role for proline at position 347." in: Human molecular genetics, Vol. 4, Issue 4, pp. 775-6, 1995 (PubMed).

Sieving, Richards, Naarendorp et al.: "Dark-light: model for nightblindness from the human rhodopsin Gly-90-->Asp mutation." in: Proceedings of the National Academy of Sciences of the United States of America, Vol. 92, Issue 3, pp. 880-4, 1995 (PubMed).

Vaithinathan, Berson, Dryja: "Further screening of the rhodopsin gene in patients with autosomal dominant retinitis pigmentosa." in: Genomics, Vol. 21, Issue 2, pp. 461-3, 1994 (PubMed).

Macke, Davenport, Jacobson et al.: "Identification of novel rhodopsin mutations responsible for retinitis pigmentosa: implications for the structure and function of rhodopsin." in: American journal of human genetics, Vol. 53, Issue 1, pp. 80-9, 1993 (PubMed).

Bennett, Sun, Karikuo: "Sequence analysis of the 5.34-kb 5' flanking region of the human rhodopsin-encoding gene." in: Gene, Vol. 167, Issue 1-2, pp. 317-20, 1996 (PubMed).

Lee, Shin, Cho et al.: "Detection of vivax malaria sporozoites naturally infected in Anopheline mosquitoes from endemic areas of northern parts of Gyeonggi-do (Province) in Korea." in: The Korean journal of parasitology, Vol. 40, Issue 2, pp. 75-81, 2002 (PubMed).

Hosts (40), (31), (3)
Reactivities (44), (33), (23), (15), (7), (5), (5), (5), (4), (4), (3), (2), (2), (2), (2), (2), (1), (1), (1), (1), (1), (1), (1)
Applications (60), (35), (27), (25), (20), (18), (15), (8), (4), (1)
Conjugates (3)
Epitopes (5), (5), (4), (2), (1), (1), (1), (1), (1), (1), (1)
back to top